Statin use in low-income and middle-income countries - Authors' reply

Lancet Glob Health. 2022 Jul;10(7):e955-e956. doi: 10.1016/S2214-109X(22)00217-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Developing Countries*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Income
  • Poverty

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors